Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EMAY is a consumer-focused healthcare device company that sells portable cardiac and sleep-monitoring products for home use. Its core offerings include portable EKG/ECG monitors, pulse oximeters, sleep oxygen monitors, and related software-enabled monitoring tools marketed directly to consumers. The company emphasizes stand-alone, easy-to-use devices that can work without constant smartphone dependence, and it highlights FDA-cleared personal EKG products for rhythm detection and recording. EMAY appears to operate commercially through U.S. and Hong Kong entities and focuses on at-home monitoring rather than therapeutics or drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EMAY.